More than 100 police officers are under investigation after 30,000 alcohol breath tests were "falsely or erroneously recorded", RNZ can reveal. Acting Deputy Commissioner Michael Johnson says the ...

The story of a 100-year-old American grandfather who continues to exercise and challenge himself in bodybuilding competitions despite his age has been reported. On the 16th, the UK Daily Mail ...

Adicet Bio Inc. (NASDAQ:ACET) shares fell Tuesday after the biotechnology company priced an $80 million direct offering, even as early safety and efficacy data from its Phase 1 trial of ADI-001 in ...

Eric Dane has vowed to “fight to the last breath” amid his battle with ALS. The “Euphoria” actor, 52, opened up about his health diagnosis during a meeting with US Rep. Frank Pallone (D-NJ) in ...

Eric Dane is determined to fight "to the last breath" amid his ALS (amyotrophic lateral sclerosis) battle. The 52-year-old actor - who revealed in April he had been diagnosed with ALS, also known as ...

To read the full story, subscribe or sign in. To vanquish pancreatic at last? Immuneering scores in phase II Sep. 25, 2025 By Randy Osborne ...

A handful of this year’s best unsung indies topline our off-the-grid streaming recommendations for this month, along with a handful of star vehicles that might have escaped your attention. By Jason ...

Phase 1 of S-100 Standards implementation is now complete after the operational release of standards S-124 Navigational Warnings and S-128 Catalogue of Nautical Products. The S-100 framework is a new ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last ...

Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last patient, last visit in its ongoing ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last ...